NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Is the Concentration of Anti-Muellerian Hormon (AMH) Depending on the Menstrual Cycle?

CompletedN/A

Sponsor: University Hospital, Basel, Switzerland

Conditions: Ovarian Failure

Interventions: blood sample and ultrasound

Countries: Switzerland

The developement of a new, stable measurement of the Antimuellerian Hormon (AMH) together with Roche Diagnostics International (Rotkreuz, CH) shall enable an automized and timely measurement of AMH values in blood samples.

Eligibility overview

Sex: FEMALE

Age: 18 Years to 40 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Regular natural menstrual cycle between 24 and 32 days
* Body Mass Index (BMI) between 19 and 26 kg/m2
* Negative serum titer for HIV, Hepatitis B and Hepatitis C
* Non-smoker
* Willingness to visit the clinic every second day of two non-consecutive menstrual cycles.

Exclusion Criteria:

* Intake of hormonal medication like contraceptives
* Pregnancy/breast feeding
* Known infertility
* Known former or actual hormonal disorder
* Polycystic ovarial syndrom (PCOS)
* Participation on another clinical trial during the last 3 months.

Locations (1)

Basel, Switzerland